This is to notify all that we have begun joint clinical research into nematode cancer detection (N-NOSE) of primary hepatic cancer, together with Tokyo University.
Regarding N-NOSE, both parties are considering whether it is possible to predict the effects of surgery, postoperative recurrence, and the prognosis by evaluating and reviewing the treatment of primary hepatic cancer and the progress following said treatment.
We as HIROTSU Bio Science Inc. (Head Office: Chiyoda-ku, Tokyo; Representative: Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”) are pleas . . .
2024.04.01On March 18, 2024, an reveiw articles on cancer screening by a third-party research team (Romania) was published in "Cancers", an oncology journ . . .
2024.03.29HIROTSU Bioscience Inc. (Head Office: Chiyoda-ku, Tokyo, Representative: Takaaki Hirotsu, hereinafter referred to as “HIROTSU) has verified the . . .
2024.02.29